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OBJECTIVES The present study sought to investigate the use of transthoracic Doppler harmonic
echocardiography (TTDHE) to evaluate changes in coronary flow dynamics due to micro-
vascular dysfunction.
BACKGROUND Coronary flow velocity reserve (CFVR) measurements by TTDHE are useful for assessing
epicardial coronary artery stenoses. It remains unclear, however, if microvascular disease can
be detected.
METHODS In 54 patients with chest pain, intracoronary Doppler (ICD) and TTDHE were used to
measure average peak velocity at baseline and hyperemia. Significant coronary lesions had
been ruled out by both angiography and intravascular ultrasound. Comparative measure-
ments were performed in the distal left anterior descending coronary artery after
intracoronary and intravenous administration of adenosine, and CFVR was calculated.
Hypertensive patients (n  25) were studied and compared to a control group (26
normotensive individuals).
RESULTS Three patients (5%) had to be excluded because of insufficient image quality or side effects.
In both groups, TTDHE-derived CFVR data correlated closely with ICD measurements
(group 1: y  0.67x  0.076, standard error of estimate [SEE]  0.25, r  0.87, p  0.001;
group 2: y  0.64x  1.11, SEE  0.26, r  0.87, p  0.001). CFVR was lower in
hypertensives than in normotensive controls (2.44  0.49 vs. 3.33  0.40, p  0.001, cut
point  2.84).
CONCLUSIONS The newly described echocardiographic method is suitable for assessing microvascular
dysfunction noninvasively and corresponds well to invasive measurements. (J Am Coll
Cardiol 2002;39:2012–8) © 2002 by the American College of Cardiology Foundation
The abnormal coronary microcirculation in left ventricular
hypertrophy due to arterial hypertension is known to reduce
cardiac oxygen supply, even in the absence of coronary artery
stenoses (1). Impaired coronary flow reserve has been
reported in patients with hypertension and diabetes mellitus
and in smokers (2–4). In addition to evaluating coronary
artery disease, intracoronary Doppler (ICD) assessment of
coronary flow velocity reserve (CFVR) is gaining impor-
tance in the detection of suspected microvascular disorders
(5,6). Transthoracic Doppler harmonic echocardiography
(TTDHE) is an ultrasound approach for the assessment of
CFVR. The technique uses contrast Doppler enhancement
to measure flows at baseline and during adenosine infusion
(7). In the majority of patients, peripheral left anterior
descending coronary artery flow can be detected and flow
velocity adequately determined (8). But it is unknown if the
method can detect microvascular dysfunction due to arterial
hypertension (9).
The present study sought to evaluate coronary flow
velocities and CFVR in arterial hypertension as assessed by
TTDHE. For this purpose, both intracoronary readings and
TTDHE were performed in hypertensive patients without
epicardial stenoses and in normotensive controls.
METHODS
Patients. From September 2000 to June 2001, 175 patients
were prospectively studied. Among these, 54 patients had
no epicardial stenoses on diagnostic coronary angiography
and intravascular ultrasound examination. A minimal lumi-
nal cross-sectional area 4 mm2 and a lumen area stenosis
50% were required for inclusion in the study. The remain-
ing 121 individuals had significant coronary artery disease.
Patients were enrolled prospectively. Patients with hyper-
trophic cardiomyopathy, dilated cardiomyopathy, valvular
heart disease, endocarditis, myocarditis and cardiac decom-
pensation were excluded from the study. Informed consent
was obtained from all patients at least 24 h before the
examinations. In one patient, transthoracic Doppler flow
was not detectable. Two patients did not tolerate intrave-
nous administration of adenosine because of flush, dyspnea
and chest discomfort. Eventually, comparative measure-
ments of coronary flow velocity were successfully carried out
in 51 patients (Table 1). Twenty-five patients had arterial
hypertension (group 1), whereas 26 patients were normo-
tensive (group 2). Patients with blood pressures of
160/90 mm Hg on repeated measurements were included
in group 1. Group 2 had no documented arterial hyperten-
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sion and a baseline blood pressure 140/85 mm Hg. Left
ventricular mass was determined according to the Penn
convention (10). The study protocol was approved by the
institutional review board (00-26-1381).
Intracoronary ultrasound measurements. Intravascular
ultrasound examination was performed with a mechanical
intravascular ultrasound system (Insight, CVIS, Boston
Scientific Scimed Inc., Maple Grove, Minnesota) using a
Microrail-catheter and motorized pullback at 0.5 mm/s.
Doppler flow data were obtained with a 0.014 in. Doppler
wire (FloWire, Jomed Inc., Helsingborg, Sweden) advanced
into the distal segments of the left anterior descending
coronary artery (5). Under baseline conditions and after
stable readings were achieved, Doppler signals were re-
corded as gray-scale spectral Doppler. Next, an intracoro-
nary bolus of 18 g adenosine was injected into the left
coronary artery over a guiding catheter, and peak hyperemic
flow was recorded at the maximal change of blood flow
velocity. Average peak velocity (APV) was determined and
CFVR calculated online from hyperemic average peak
velocity (hAPV) and baseline average peak velocity (bAPV)
as described (4).
Echocardiographic coronary flow measurement. Trans-
thoracic Doppler harmonic echocardiography examinations
were done with an ultrasonographic unit (Sequoia C256,
Acuson Corp., Mountain View, California) equipped with a
broadband transducer with second harmonic capability
(3V2c). In a short-axis view of the left ventricle, the anterior
groove was examined for diastolic blood flow under guid-
ance by color Doppler flow mapping to identify the distal
left anterior descending coronary artery (7). Two-
dimensional and contrast-enhanced color Doppler imaging
was routinely performed in the second-harmonic mode
using 1.7 MHz for transmitting and 3.5 MHz for receiving
ultrasound waves. In contrast, spectral Doppler data were
obtained with the fundamental imaging mode at 2.5 MHz.
If the angle between Doppler beam and coronary flow
exceeded 30°, the standard software package of the ultra-
sound unit was used for angular correction. During con-
tinuous peripheral intravenous infusion of 200 mg/ml
Levovist (Schering AG, Berlin, Germany) at 0.5 to
2.0 ml/min, significant portions of the studies were captured
at end-expiration and digitally stored in cine-loop format
and as spectral Doppler still frames for offline analysis. Peak
systolic velocity (PSV), peak diastolic velocity (PDV), mean
systolic velocity (MSV), mean diastolic velocity (MDV),
and APV were measured at baseline and under hyperemic
conditions from at least two cardiac cycles, and CFVR was
calculated (Fig. 1). After coronary flow measurement under
baseline conditions, adenosine was intravenously infused at
a rate of 50 g/kg/min and increased in steps of 1 min to
doses of 75 and 100 g/kg/min, and finally to a dose of
140 g/kg/min, which was maintained for another 2 min.
Statistical analysis. Parametric data are expressed as
mean  SD and were tested by use of the unpaired
two-tailed Student t test for group distinction. The paired
two-tailed Student t test with Bonferroni correction was
employed to analyze changes of flow velocities due to
increasing doses of adenosine. Nonparametric data were
tested employing the chi-square test with one degree of
freedom. The optimal cutoff points were determined by
receiver operating characteristic curves (ROC analysis) us-
ing SPSS for Windows (release 10.0.1, SPSS Inc., Chicago,
Illinois), and the sensitivity and specificity of TTDHE
measurements for group distinction were determined ac-
cording to:
Sensitivity
True positives
True positives False negatives
 100%
Specificity
True negatives
True negatives False positives
 100%
Linear correlation analysis was used to compare TTDHE
with intracoronary data on APV and CFVR. Analyses
included the determination of regression equations, corre-
lation coefficients, and standard error of the estimate. The
statistics program StatView for Macintosh (release 5, Aba-
cus Concepts Inc., Berkeley, California) was employed for
Abbreviations and Acronyms
APV  average peak velocity
bAPV  baseline average peak velocity
bMDV  baseline mean diastolic velocity
bMSV  baseline mean systolic velocity
bPSV  baseline peak systolic velocity
CFVR  coronary flow velocity reserve
hAPV  hyperemic average peak velocity
ICD  intracoronary Doppler
MDV  mean diastolic velocity
MSV  mean systolic velocity
PDV  peak diastolic velocity
PSV  peak systolic velocity
TTDHE  transthoracic Doppler harmonic
echocardiography
Table 1. Patient Characteristics
Total number of patients 51
Women 21 (41.2%)
Men 30 (58.8%)
Age (yrs) 55  11* (range 20–75)
Hemodynamic parameters†
HR (beats/min) 64  13*
sBP (mm Hg) 136  23*
dBP (mm Hg) 77  11*
mBP (mm Hg) 93  13*
Stress ECG
Number of patients 51
Adequate exercise and end points 44
Positive 18
Negative 26
*Mean  standard deviation; †at baseline conditions during echocardiographic
Doppler examination.
BP  blood pressure; d  diastolic; ECG  electrocardiogram; HR  heart rate;
m  mean; s  systolic.
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these analyses. Differences between TTDHE and intracoro-
nary measurements and limits of agreement were displayed
according to Bland-Altman (11). Statistical significance was
defined as a p  0.05.
RESULTS
Group characteristics. Between groups 1 and 2, there were
no differences in age, gender, men-women ratio and heart
rate. Patients were also categorized according to risk factors
for microvascular dysfunction (12). Group 1 had signif-
icantly higher values of rate-pressure product, systolic,
diastolic and mean blood pressure than group 2. In
contrast, the proportions of smokers and diabetics were
not significantly different. Left ventricular mass was
higher in group 1 than in group 2, but not to a significant
degree (Table 2).
Linear correlation analyses and accuracy. Separate analy-
ses for both groups revealed close correlation between ICD
and TTDHE measurements of bAPV (Fig. 2A). In group
1, intracoronary and echocardiographic readings were in
agreement with respect to the partly increased bAPV values.
In contrast to group 2, flow velocity measured by TTDHE
was slightly underestimated in group 1 (Fig. 2A). This
underestimation occurred exclusively in those patients of
group 1 who presented with increased bAPV. Thus, the
mean differences between ICD and TTDHE measurements
were higher in group 1 than in group 2. As shown for
comparative measurements of bAPV, correlation coeffi-
cients and differences indicated good agreement between
ICD and TTDHE measurements of hAPV, although the
correlation was better in group 1 than in group 2 (Fig. 2B).
In contrast to bAPV, measurements of hAPV revealed
lower values in group 1 than in group 2. The differences
between ICD and TTDHE readings were comparable in
both groups. The highest correlation coefficients between
ICD and TTDHE data acquisition were found for CFVR
(Fig. 2C), also showing the smallest differences between
both approaches. TTDHE underestimated CFVR slightly
(Table 2).
Doppler flow measurements in hypertensives. In group
1, bPSV, bMSV and bAPV were significantly higher than
in group 2. The same was evident at the lowest adenosine
infusion rate. Neither in group 1 nor in group 2 was a
significant APV increase over baseline conditions detectable
at an adenosine infusion rate of 50 g/kg/min. But with
adenosine infusion rates above 50 g/kg/min, APV in-
creased more slowly in group 1 than in group 2. Finally,
hAPV was lower in group 1 than in group 2, although the
mean differences of all hyperemic flow parameters were not
significantly different between both groups. Nevertheless,
TTDHE-derived CFVR was significantly lower in group 1
than in group 2 (Table 3). Coronary flow velocity reserve
was the most distinctive echocardiographic parameter, dis-
criminating both groups with the highest sensitivity and
Figure 1. Echocardiographic readings of coronary flow velocity. bAPV  baseline average peak velocity; hAPV  hyperemic average peak velocity.
Table 2. Group Characteristics Including Results of
Intracoronary Doppler Measurements
Variable
Group 1
(n  25)
Group 2
(n  26) Difference
Men/women ratio 14/11 16/10 2  0.16, NS
Age (yrs) 58  9 53  12 NS
Diabetes mellitus* 2 2 2  0.0013, NS
Smoking 7 6 2  0.16, NS
HR (beats/min) 63  10 66  16 NS
sBP (mm Hg) 154  16 118  13 p  0.0001
dBP (mm Hg) 85  6 68  8 p  0.0001
mBP (mm Hg) 100  14 86  8 p  0.0001
Rate-pressure
product
9,665  1,469 7,837  2,357 p  0.008
LV mass 153  51 134  32 NS
bAPV (cm/s) 20.0  9.40 15.2  4.68 p  0.0239
hAPV (cm/s) 48.0  16.9 51.4  14.5 NS
CFVR 2.50  0.63 3.49  0.54 p  0.0001
Parametric data are expressed as mean  SD. Left ventricular mass is determined
according to the American Society of Echocardiography convention. *Noninsulin-
dependent diabetes mellitus in all cases.
APV  average peak velocity; b  baseline; BP  blood pressure; d  diastolic;
CFVR  coronary flow velocity reserve; h  hyperemic; HR  heart rate; LV  left
ventricle; m  mean; NS  not significant; s  systolic.
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specificity at its optimal cut point (Fig. 3). Other indices,
especially bMDV and bAPV, as well as PSV and MSV at an
infusion rate of 50 g/kg/min, showed partly higher speci-
ficity but markedly lower sensitivity at their particular
optimal cutoff points than CFVR (Table 4).
DISCUSSION
This is the first study to show that TTDHE is capable of
measuring CFVR with similar results as intracoronary
Doppler in patients with and without arterial hypertension,
Figure 2. Linear regression analyses including Bland-Altman plots of differences (11) between intracoronary and Doppler echocardiographic measurements.
Some symbols represent more than one pair of data. (A) Comparison of intracoronary vs. echocardiographic baseline average peak velocity (bAPV) in group
1 and group 2; (B) comparison of intracoronary vs. echocardiographic hyperemic average peak velocity (hAPV) in both groups; (C) comparison of
intracoronary vs. echocardiographic coronary flow velocity reserve (CFVR) in both groups. Open circle  group 1; filled circle  group 2. ICD 
intracoronary Doppler; SD  standard deviation; SEE  standard error of estimate; TTDHE  transthoracic Doppler harmonic echocardiography.
2015JACC Vol. 39, No. 12, 2002 Bartel et al.
June 19, 2002:2012–8 Echocardiographic Assessment of Microvascular Function
and that TTDHE is suitable to assess microvascular func-
tion and dysfunction. Promising new technical develop-
ments allow CFVR measurements with transthoracic
Doppler echocardiographic methods, as demonstrated in
recently published investigations (7,13). Moreover,
TTDHE has already been extensively validated as a useful
method to assess coronary artery disease (14,15).
Alterations of coronary flow dynamics in arterial hyper-
tension. Significant coronary lesions were ruled out with
intravascular ultrasound, which allows to reliably assess
difficult anatomic situations including angiographic super-
imposition of side branches. The results of our investigation
clearly indicate that two independent functional abnormal-
ities impair CFVR in arterial hypertension, that is, increase
in basal flow velocity and decrease in vasodilative response
to adenosine. This particular finding is in agreement with
early results by Hoffman (16). Especially at higher adeno-
sine doses, APV increased less when arterial hypertension
was present. Arterial hypertension is well known to lead to
pathologic left ventricular hypertrophy and structural and
functional alterations of intramyocardial coronary arterioles,
usually resulting in impaired coronary flow dynamics and
lowered CFVR in particular (9). Structural remodeling of
intramyocardial arterioles and the accumulation of fibrillar
collagen seem to be decisive factors for a reduced coronary
dilatory reserve (17). The increased CFVR that can be
demonstrated by transthoracic Doppler echocardiography
after aortic valve replacement for aortic stenosis, and that
parallels the regression of left ventricular hypertrophy,
shows that hypertrophy plays another important role in this
respect (18).
Value of TTDHE. The present results clearly demonstrate
that echocardiographic readings of CFVR are in good
agreement with intracoronary data, no matter what the
microvascular function is. As previously reported, echocar-
diography tends to slightly underestimate APV (8). This
Table 3. Transthoracic Doppler Harmonic Echocardiography Results in Both Groups
Adenosine Group PSV (cm/s) MSV (cm/s) PDV (cm/s) MDV (cm/s) APV (cm/s) CFVR
Baseline 1 13.4  4.96 11.9  4.54 28.6  9.22 23.9  8.11 19.0  6.41 —
2 10.3  2.78 9.15  2.60 25.1  7.76 19.7  4.75 15.1  3.35 —
Difference p  0.0082 p  0.0117 NS p  0.0273 p  0.0091 —
50 U 1 15.5  6.87* 14.0  6.19* 29.8  0.79 25.0  8.46 20.6  6.73 —
2 10.8  2.17 10.1  2.49 25.4  7.51 20.6  5.22 16.1  3.33 —
Difference p  0.0017 p  0.0040 NS p  0.0285 p  0.0035 —
75 U 1 21.5  11.3* 18.8  9.06* 37.5  12.6* 32.0  10.9* 27.0  9.67* —
2 17.2  8.23* 15.9  7.73* 34.8  17.1* 29.4  13.8* 23.4  11.3* —
Difference NS NS NS NS NS —
100 U 1 29.4  13.9* 26.1  11.3* 52.6  20.4* 44.8  18.0* 36.3  13.6* —
2 26.9  13.1* 24.3  11.4* 51.3  20.3* 43.6  17.0* 35.3  13.7* —
Difference NS NS NS NS NS —
140 U 1 36.1  11.8* 33.2  10.9* 63.4  20.1* 55.0  16.2* 45.4  13.0* 2.44  0.49
(Hyperemia) 2 37.8  11.3* 34.5  9.19* 70.6  16.8* 59.6  11.7* 48.8  8.95* 3.33  0.40
Difference NS NS NS NS NS p  0.0001
Data are expressed as mean  SD. *Significant increase compared to next lower dosage of adenosine (p  0.05 after alpha-adjustment according to Bonferroni).
APV  average peak velocity; CFVR  coronary flow velocity reserve; MDV  mean diastolic velocity; MSV  mean systolic velocity; NS  not significant; PDV  peak
diastolic velocity; PSV  peak systolic velocity; U  g/kg/min.
Figure 3. Calculation of the optimal cutoff point between group 1 and
group 2 by use of receiver operating characteristic curve with respect to
coronary flow velocity reserve. Dotted line shows a random distribution.
AUC  area under the receiver operating characteristic curve; SEM 
standard error of the mean.
Table 4. Sensitivity and Specificity of Echocardiographic
Measurements with Respect to Group Distinction
Variable
Sensitivity
(%)
Specificity
(%)
Optimal cutoff
point (cm/s)
bPSV 68 58 11.3
bMSV 56 77 10.7
bMDV 48 85 23.3
bAPV 68 66 15.5
PSV (50 g/kg/min) 56 100 14.7
MSV (50 g/kg/min) 56 96 13.7
MDV (50 g/kg/min) 64 69 21.0
APV (50 g/kg/min) 72 54 16.3
CFVR 80 88 2.84
APV  average peak velocity; b  baseline; CFVR  coronary flow velocity reserve;
MDV mean diastolic velocity; MSV  mean systolic velocity; PSV  peak systolic
velocity.
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report also demonstrates that hypertensives can be clearly
distinguished from nonhypertensives on the basis of APV,
PSV, MSV and MDV at baseline and at a low dose of
adenosine. The capability of a detailed systolic and diastolic
coronary flow velocity analysis during gradual increase of
hyperemia, represents an advantage of TTDHE in compar-
ison with the invasive approach. As determined by this
technique, CFVR was found to be even more distinctive
than the other flow velocity parameters. It is interesting to
note that the sensitivity and specificity we found for echo-
cardiographic CFVR match the sensitivity and specificity of
CFVR for the detection of coronary artery disease (19). The
cutoff point for distinguishing normal from coronary flow
dynamics impaired by microvascular disease is very close to
the 3.0 value previously reported, and it exceeds the cutoff
value recently proposed for microvascular dysfunction in
women by only a very small amount (12,20). The estab-
lished invasive flow measurement techniques provide com-
prehensive information on the functional significance of
epicardial coronary stenoses and on microvascular dysfunc-
tion (20).
Clinical implications. As previously shown, TTDHE is
suitable for assessing functional disorders of coronary flow
dynamics noninvasively when following patients (18).
Therefore, TTDHE can be considered capable of assessing
microvascular function and may also become a valuable
noninvasive tool for evaluating drug effects on the coronary
microcirculation. As an extension of this work, it would be
also interesting to evaluate the relation between the results
of stress testing and CFVR in hypertensive patients with
normal coronary arteries. Obviously, coronary stenosis and
microvascular dysfunction have the same effect on CFVR,
but increased baseline flow may be more related to dysfunc-
tional microcirculation (21).
Study limitations. A small number of noninsulin-
dependent diabetics and smokers were included in the study
(2,3,20). Nevertheless, comparison of coronary flow dynam-
ics was not markedly altered, because both groups had
similar proportions of patients. The fact that echocardio-
graphic coronary flow velocity data were obtained from the
very distal coronary arteries and that intracoronary measure-
ments were performed more proximally can lead to small
differences between both methods (8,12). The different
routes of adenosine administration for the intracoronary and
echocardiographic measurements may cause TTDHE to
slightly underestimate APV in comparison with invasive
readings (8). These dissimilarities appear to affect hAPV
measurements in the two groups differently. In addition, we
are now aware that in some patients higher doses of
intracoronary adenosine are needed for maximum hyper-
emia. The doses used are nevertheless in agreement with
standard doses used in international multicenter trials, such
as the DEBATE trial (22). Because of the inability of
TTDHE to measure CFVR in other vessels than in the left
anterior descending coronary artery, reference measure-
ments in patients with abnormal CFVR in the left anterior
descending coronary artery were not carried out.
Conclusions. In arterial hypertension, microvascular func-
tion and dysfunction can be reliably assessed noninvasively
by coronary flow measurement using TTDHE. Specific
changes of coronary flow dynamics detectable by incremen-
tal induction of hyperemic conditions seem to be character-
istic for hypertensives. These results promise that TTDHE
might also be valuable for assessing the microcirculation in
other clinical conditions.
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